An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Cited by (451)

Items 201–300 of 451

1. LncRNA DNAJC3-AS1 Regulates Fatty Acid Synthase via the EGFR Pathway to Promote the Progression of Colorectal Cancer
   Yanyan Tang, Rui Tang, Mengtian Tang, Ping Huang, Zhiqiang Liao, Jumei Zhou, Lianqing Zhou, Min Su, Pan Chen, Jiarui Jiang et al. · 2021 · Frontiers in Oncology
2. The HDL particle composition determines its antitumor activity in pancreatic cancer
   Raimund Oberle, Kristina Kührer, Tamina Österreicher et al. · 2022 · Life Science Alliance
3. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury
   Zhengyang Wang, Xiaoming Yang, Liang Chen, Xiuling Zhi, Hanyu Lu, Yanxia Ning, Joe Poh-Sheng Yeong, SF Chen, Lianhua Yin, Xinhong Wang et al. · 2016 · Archives of Toxicology
4. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas
   Chiao-Pei Cheng, Li‐Chun Huang, Yung‐Lung Chang · 2016 · Oncotarget
5. STAT3 activation of SCAP-SREBP-1 signaling upregulates fatty acid synthesis to promote tumor growth
   Yunzhou Fan, Rui Zhang, Chao Wang, Meixia Pan, Feng Geng, Yaogang Zhong, Huali Su, Yongjun Kou, Xiaokui Molly Mo, Étienne Lefai et al. · 2024 · Journal of Biological Chemistry
6. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme
   Mekala Janaki Ramaiah, Rohil Kumar Kurappalli · 2021 · Molecular Biology Reports
7. Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
   Xueyao Huang, Xuan Wei, Sijing Qiao, Xue Zhang, Rui Qiang Li, Shunxue Hu, Hongluan Mao, Peishu Liu · 2021 · Cancer Management and Research
8. Activation of liver X receptor up‐regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms
   Maria Teresa Bilotta, Maria Pia Abruzzese, Rosa Molfetta, Gianluca Scarno, Cinzia Fionda, Alessandra Zingoni, Alessandra Soriani, Tina Garofalo, Maria Teresa Petrucci, Maria Rosaria Ricciardi et al. · 2019 · The FASEB Journal
9. Lipid metabolism reprogramming in head and neck cancer
   Jinfeng Liang, Li Lin, Limei Li, Xiaoying Zhou, Zhe Zhang, Yi Huang, Xue Xiao · 2023 · Frontiers in Oncology
10. Lipid metabolism: the potential therapeutic targets in glioblastoma
    Lu Lu, Yan Zhang, Yuzhong Yang, Meihua Jin, A Ma, Xu Wang, Qiuyu Zhao, Xuemei Zhang, Jinhua Zheng, Xiang Zheng · 2025 · Cell Death Discovery
11. The dysfunctional lipids in prostate cancer.
    Qiang Dang, Yuan Chen, Jer‐Tsong Hsieh · 2019 · PubMed Central
12. Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia
    Matthias Floeth, Sandra Elges, Joachim Gerß, Christian Schwöppe, Torsten Keßler, Tobias Herold, Eva Wardelmann, Wolfgang E. Berdel, Georg Lenz, Jan‐Henrik Mikesch et al. · 2020 · British Journal of Haematology
13. LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers
    Shanshan Liu, Benzheng Jiao, Hongguang Zhao, Xinyue Liang, Fengyan Jin, Xiaodong Liu, Ji‐Fan Hu · 2023 · Advanced Science
14. The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma
    Zeynab Nayernia, Laurent Turchi, Erika C. Cosset et al. · 2013 · Biomaterials
15. Site-1 protease, a novel metabolic target for glioblastoma
    Beth T. Caruana, Aleksandra Skoric, Andrew John Brown · 2017 · Biochemical and Biophysical Research Communications
16. SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC
    Christian Felipe Ruiz, Emily D. Montal, John D. Haley, Alex J. Bott, John D. Haley · 2020 · The FASEB Journal
17. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities
    Prasanna Srinivasan Ramalingam, Sujatha Elangovan, Mekala Janaki Ramaiah, Sivakumar Arumugam · 2024 · Frontiers in Cell and Developmental Biology
18. Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B
    Rebecca L. Hamm, Maen Zeino, Simon Frewert · 2014 · Toxicology and Applied Pharmacology
19. Discovery of new LXRβ agonists as glioblastoma inhibitors
    Hao Chen, Ziyang Chen, Zizhen Zhang, Yali Li, Shu-Shu Zhang, Fuqiang Jiang, Junkang Wei, Peng Ding, Huihao Zhou, Qiong Gu et al. · 2020 · European Journal of Medicinal Chemistry
20. Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators
    Diego Gómez‐Coronado, Miguel Angel Lasunción, Javier Martı́nez-Botas, María E. Fernández‐Suárez · 2020 · Seminars in Cancer Biology
21. The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease
    Nienke M. van Loon, Dan Lindholm, Noam Zelcer · 2019 · Current Opinion in Lipidology
22. Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C/EBPα/SREBP-1 pathway
    Bo Pang, Juanjuan Zhang, Xi Zhang · 2021 · Acta Biochimica et Biophysica Sinica
23. Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors
    Trang Thi Thu Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, Chang Shu, Elena Bianchetti, Georg Karpel‐Massler, Markus David Siegelin · 2019 · Cancers
24. Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM
    Andrew McKinney, Olle R. Lindberg, Jane R. Engler, Katharine Y. Chen, Anupam Kumar, Henry Z. Gong, Kan V. Lu, Erin F. Simonds, Timothy Francis Cloughesy, Linda M. Liau et al. · 2019 · Molecular Cancer Therapeutics
25. EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
    Tingting Chen, Jie Xu, Weihua Fu · 2020 · Frontiers in Oncology
26. Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma
    Hye Jin Nam, Young Eun Kim, Byoung-San Moon, Hyun Young Kim, Daeyoung Jung, Seungho Choi, Jeong Woon Jang, Do‐Hyun Nam, Heeyeong Cho · 2021 · iScience
27. Mitochondrial Cholesterol and the Paradox in Cell Death
    Carmen García‐Ruiz, Vicent Ribas, Anna Baulies, José Carlos Fernández-Checa · 2016 · Handbook of experimental pharmacology
28. Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy
    Teng Tu, Hongying Zhang, Huanji Xu · 2023 · Frontiers in Oncology
29. Label-Free Raman Spectromicroscopy Unravels the Relationship between MGMT Methylation and Intracellular Lipid Accumulation in Glioblastoma
    Nana Wang, Jiejun Wang, Pu Wang, Nan Ji, Shuhua Yue · 2023 · Analytical Chemistry
30. Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization
    Flavie Courtaut, Valentin Dérangère, Angélique Chevriaux · 2015 · Oncotarget
31. Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts
    Joshua C. Doloff, David J. Waxman · 2015 · BMC Cancer
32. Metabolic reprogramming in cancer: signaling pathways and therapeutic targets
    Shi Dong, Xiong Lei · 2026 · Molecular Cancer
33. The metabolomic landscape plays a critical role in glioma oncogenesis
    Kenta Masui, Webster K. Cavenee, Paul S. Mischel, Noriyuki Shibata · 2022 · Cancer Science
34. Emerging Lipid Targets in Glioblastoma
    Ammar Darwish, Milán Pammer, Ferenc Gallyas, László Vı́gh, Zsolt Balogi, Kata Juhász · 2024 · Cancers
35. Lipid metabolism and cancer progression: The missing target in metastatic cancer treatment
    Maxwell Omabe, Martin Ezeani, Kenneth Nwobini Omabe · 2014 · Journal of Applied Biomedicine
36. mRNA levels of low-density lipoprotein receptors are overexpressed in the foci of deep bowel endometriosis
    Luciano Gibran, Raul Cavalcante Maranhão, Elaine Rufo Tavares, Priscila O. Carvalho, Maurício Simões Abrão, Sérgio Podgaec · 2016 · Human Reproduction
37. Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway
    Jiachuan Yu, Yuanyuan Luo, Qingping Wen · 2019 · Journal of Experimental & Clinical Cancer Research
38. NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis
    So-Hyun Yoon, Hoe Suk Kim, Ryong Nam Kim · 2020 · BMC Cancer
39. DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy
    Xiang Cheng, Feng Geng, Deliang Guo · 2020 · Molecular & Cellular Oncology
40. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
    Hongbin Zhang, Ke Xu, Qin Xiang et al. · 2020 · Genes & Diseases
41. Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
    Hiromu Yano, Yukio Fujiwara, Hasita Horlad, Chang Pan, Keitaro Kai, Daisuke Niino, Kumiko Ohsawa, Morihiro Higashi, Kisato Nosaka, Yutaka Okuno et al. · 2022 · Cancer Science
42. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers
    Anna Røssberg Lauridsen, Aikaterini Skorda, Nuggi Ingholt Winther, Marie Lund Bay, Tuula Kallunki · 2024 · Journal of Experimental & Clinical Cancer Research
43. Cholesterol homeostasis and autophagic flux in perifosine-treated human hepatoblastoma HepG2 and glioblastoma U-87 MG cell lines
    Pablo Ríos‐Marco, Antonio Ríos, José M. Jiménez‐López, Maria Paz Carrasco-Jimenez, Carmen Marco · 2015 · Biochemical Pharmacology
44. Cholesterol: An Achilles’ Heel for Glioblastoma?
    Zhenyi An, William A. Weiss · 2016 · Cancer Cell
45. Lipidomic analysis and diagnosis of glioblastoma multiforme with rapid evaporative ionization mass spectrometry
    Jianfeng Ma, Ting Li, Huiyao Chen · 2021 · Electrophoresis
46. Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance
    Justine Bailleul, Erina Vlashi · 2023 · Antioxidants and Redox Signaling
47. Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production
    Thu P. Nguyen, Wentian Wang, Alex C. Sternisha, Chase D. Corley, Hua-Yu Leo Wang, Xiaoyu Wang, Francisco Ortiz, Sang-Kyun Lim, Kalil G. Abdullah, Luis F. Parada et al. · 2023 · Cell chemical biology
48. Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
    Laura Zarzuela, Raúl V. Durán, Mercedes Tomé · 2023 · Molecular Oncology
49. The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials
    Hyun Joo Jang, Hyeong Su Kim, Jung Han Kim, Jin Lee · 2018 · Journal of Clinical Medicine
50. GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients
    Xuchen Hu, Ken Matsumoto, Rachel S. Jung, Thomas A. Weston, Patrick J. Heizer, Cuiwen H. He, Norma P. Sandoval, Christopher M. Allan, Yiping Tu, Harry V. Vinters et al. · 2019 · eLife
51. Lipid Metabolism in Cancer Cells
    Minhua Zheng, Wei Wang, Jun Liu, Xiao Zhang, Rui Zhang · 2021 · Advances in experimental medicine and biology
52. LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma
    Angélina Acier, Magali Godard, Fanny Gassiot, Pascal Finetti, Marion Rubis, Jonathan Nowak, François Bertucci, Juan Iovanna, Richard Tomasini, Pascaline Lécorché et al. · 2021 · Communications Biology
53. ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma
    Roberto Ferrarese, Annalisa Izzo, Geoffroy Andrieux, Simon Lagies, Johanna Paulina Bartmuss, Anie P. Masilamani, Alix Wasilenko, Daniela Osti, Stefania Faletti, Rana Schulzki et al. · 2022 · Life Science Alliance
54. Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression via targeting EGFR
    Yewei Huang, Li-Tian Wang, Meng Zhang, Yan Nie, Jin-Bo Yang, WenLuer Meng, Xuanjun Wang, Jun Sheng · 2023 · Food & Function
55. Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
    Jie Ni, Leilei Zhou, Li Jun Ding, Xue‐qin Zhang, Xia Zhao, Huizi Li, Haixia Cao, Siwen Liu, Zhuo Wang, Rong Ma et al. · 2018 · Cancer Medicine
56. Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas
    Ying Zhou, Long Wang, Chaojia Wang, Yilin Wu, Dongmei Chen, Tae Ho Lee · 2020 · Archives of Pharmacal Research
57. Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway
    Bhrigu Kumar Das, Rachel M. Knott, Pramod Channabasappa Gadad · 2021 · Future Journal of Pharmaceutical Sciences
58. Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
    Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng, Lushan Yu · 2023 · Frontiers in Immunology
59. Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy
    Nayeon Shim, Hanhee Cho, Seong Ik Jeon, Kwangmeyung Kim · 2023 · Journal of Pharmaceutical Investigation
60. The macroenviromental control of cancer metabolism by p62
    Jianfeng Huang, Maria Teresa Díaz-Meco, Jorge Moscat · 2018 · Cell Cycle
61. Akt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines
    Qingbo Wang, Bo Shen, Xiaobing Qin, Siwen Liu, Jifeng Feng · 2019 · Translational Cancer Research
62. Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics
    Ruchika Dadhich, Shobhna Kapoor · 2022 · Molecular and Cellular Biochemistry
63. ABCA1 transporter reduces amphotericin B cytotoxicity in mammalian cells
    Ambroise Wu, Ewa Grela, Karolina Wójtowicz, Nina Filipczak, Yannick Hamon, Rafał Luchowski, Wojciech Grudziński, Olga Raducka-Jaszul, Mariusz Gagoś, Andrzej Szczepaniak et al. · 2019 · Cellular and Molecular Life Sciences
64. Small ring has big potential: insights into extrachromosomal DNA in cancer
    Yihao Wang, Rui Huang, Guopei Zheng, Jianfeng Shen · 2021 · Cancer Cell International
65. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics
    Sahiti Chamarthy, Mekala Janaki Ramaiah · 2023 · Metabolic Brain Disease
66. Targeting cellular respiration as a therapeutic strategy in glioblastoma
    Enyuan Shang, Trang Thi Thu Nguyen, Mike‐Andrew Westhoff · 2023 · Oncotarget
67. A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration
    Yili Chen, Kaping Lee, Yanchun Liang, Shuhang Qin, Yuan Zhu, Junxiu Liu, Shuzhong Yao · 2021 · Frontiers in Genetics
68. Analysis of SCAP N-glycosylation and Trafficking in Human Cells
    Chunming Cheng, Jeffrey Yunhua Guo, Feng Geng, Xiaoning Wu, Xiang Cheng, Qiyue Li, Deliang Guo · 2016 · Journal of Visualized Experiments
69. Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma
    Safet Zekanovic, Puspha Achaiber Sing, Sieger Leenstra, Martine L.M. Lamfers · 2025 · Cell Death and Disease
70. Hyperspectral stimulated Raman scattering microscopy facilitates differentiation of low-grade and high-grade human prostate cancer
    Xun Chen, Sishan Cui, Shuai Yan · 2021 · Journal of Physics D Applied Physics
71. Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
    Jian V. Huang, Giordano Sigon, Benjamin Harvey Mullish, Dan Wang, Rohini Sharma, Pinelopi Manousou, Roberta Forlano · 2023 · Nutrients
72. Extracellular proximal interaction profiling by cell surface–targeted TurboID reveals LDLR as a partner of liganded EGFR
    Rasha Al Mismar, Payman Samavarchi‐Tehrani, Brendon Seale · 2024 · Science Signaling
73. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro
    Yong Hu, Jialan Zang, Haixia Cao et al. · 2017 · Oncotarget
74. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
    Junlong Wu, Fangning Wan, Haoyue Sheng · 2017 · Journal of Cancer
75. Bioinformatics analysis of gene expression profiles to diagnose crucial and novel genes in glioblastoma multiform
    Chanabasayya Mallikarjunayya Vastrad, Basavaraj Mallikarjunayya Vastrad · 2018 · Pathology - Research and Practice
76. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts
    Dali Li, Shenglan Li, Allen Z. Xue, Laura A. Smith Callahan, Ying Liu · 2020 · Medicine
77. Shedding light on the roles of liver X receptors in cancer by using chemical probes
    Lorenzo Pontini, Maura Marinozzi · 2020 · British Journal of Pharmacology
78. Cholesterol metabolism and tumor
    Ying Meng, Qifei Wang, Zhimin LYU · 2021 · Journal of Zhejiang University (Medical Sciences)
79. Cholesterol Derivatives as Promising Anticancer Agents in Glioblastoma Metabolic Therapy
    Khouloud Sassi, Thomas Nury, Mohammad Hadi Samadi, Fatma Ben Aissa‐Fennira, Anne Véjux, Gérard Lizard · 2021 · Exon Publications eBooks
80. Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response
    Marco Pizzocri, Francesca Re, Elisabetta Stanzani, Beatrice Formicola, Matteo Tamborini, Eliana Lauranzano, Federica Ungaro, Simona Rodighiero, Maura Francolini, Maria Gregori et al. · 2021 · Neuro-Oncology Advances
81. Synthesis of Apolipoprotein B Lipoparticles to Deliver Hydrophobic/Amphiphilic Materials
    Hsueh‐Liang Chu, Tsai-Mu Cheng, Hung‐Wei Chen, Fu-Hsuan Chou, Yu‐Chuan Chang, Hsin‐Yu Lin, Shih-Yi Liu, Yu‐Chuan Liang, Ming-Hua Hsu, Dian-Shyeu Wu et al. · 2013 · ACS Applied Materials & Interfaces
82. 3‐Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines
    Craig Heath Kuder, Megan Moore Weivoda, Ying Zhang · 2015 · Lipids
83. LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in�vitro by inhibiting Akt-NF-κB activation
    Siwen Liu, Haixia Cao, Dan Chen, Shaorong Yu, Huanhuan Sha, Jianzhong Wu, Rong Ma, Zhuo Wang, Changwen Jing, Junying Zhang et al. · 2018 · Oncology Letters
84. Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition
    Aurélia Nguyen, François‐Marie Moussallieh, Alan G. Mackay, A. Ercüment Çiçek, Andres Hugo Coca, Marie Pierre Chenard, Noëlle Weingertner, Benoît Lhermitte, Éric Letouzé, Éric Guérin et al. · 2017 · Oncotarget
85. FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma
    Eleonora Vecchio, Raffaella Gallo, Selena Mimmi, Debora Gentile, Caterina Giordano, Emilio Straface, Rossana Marino, Carmen Caiazza, Arianna Pastore, Maria Rosaria Ruocco et al. · 2025 · Communications Biology
86. STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells
    Kailing Pan, Bin Hu, Lude Wang · 2022 · Journal of Molecular Neuroscience
87. Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR ‐ TKI treatment
    Haixia Cao, Shaorong Yu, Dan Chen · 2016 · FEBS Open Bio
88. Molecular mechanism of liver X receptors in cancer therapeutics
    Qiang Wang, Jing Wang, Jiayou Wang, Heng Zhang · 2021 · Life Sciences
89. Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects
    Jinyi Zhang, Xueqing Kong, Boyan Zhou, Rui Li, Zhaoan Yu, Jinrong Zhu, Qing Xi, Yan Li, Zichao Zhao, Rongxin Zhang · 2025 · Molecular Aspects of Medicine
90. Pathogenic Role of 25-Hydroxycholesterol in Cancer Development and Progression
    Sura Salman Ejam, Raed Obaid Saleh, Maria Jade Catalan Opulencia, Mazin A. A. Najm, Aziza Makhmudova, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Moaed Emran Al-Gazally, Ali Thaeer Hammid, Yasser Fakri Mustafa et al. · 2022 · Future Oncology
91. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began to Where We Are Going
    Patrick D. Sutphin, Daniel Lamus, Sanjeeva Prasad Kalva · 2019 · Molecular and translational medicine
92. Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution
    Runze Qiu, Jingjing Zhang, Chun Ge, Yue Zhong, Suo Liu, Qingquan Li, Jianjun Zou, Hongwei Fan, Yingbin Li · 2022 · Evidence-based Complementary and Alternative Medicine
93. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
    Jyotirmayee Talapatra, Mamatha M. Reddy · 2023 · Cancers
94. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
    Yutong Zhao, Cheng Qin, Lin Chen, Zeru Li, Bangbo Zhao, Tianyu Li, Xiangyu Zhang, Weibin Wang · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
95. Research progress on cholesterol metabolism and tumor therapy
    Zewen Chu, Lei Fang, Yan‐Wei Xiang, Yue Ding · 2025 · Discover Oncology
96. Nuclear receptors as regulators of stem cell and cancer stem cell metabolism
    Zoltán Simándi, Ixchelt Cuaranta‐Monroy, László Nagy · 2013 · Seminars in Cell and Developmental Biology
97. 5-Azacytidine engages an IRE1α-EGFR-ERK1/2 signaling pathway that stabilizes the LDL receptor mRNA
    Nourhen Mnasri, Maya Mamarbachi, Bruce G. Allen, Gaétan Mayer · 2017 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
98. Atherosclerosis and carcinoma: Two facets of dysfunctional cholesterol homeostasis
    Nimai Chand Chandra · 2020 · Journal of Biochemical and Molecular Toxicology
99. Correlations of MUC15 overexpression with clinicopathological features and prognosis of glioma
    Wen-Bing Yang, Chengyan Li · 2014 · Journal of Huazhong University of Science and Technology [Medical Sciences]
100. Nuclear Receptor LXR as a Novel Therapeutic Antitumoral Target in Glioblastoma
     Antonio Moschetta · 2011 · Cancer Discovery